Scynexis (SCYX) Long-Term Investments (2016 - 2026)
Scynexis' (SCYX) quarterly Long-Term Investments came in at $13.2 million in Q1 2026, little changed YoY from $13.2 million in Q1 2025, and down 19.04% on a QoQ basis from $16.2 million in Q4 2025.
Scynexis (SCYX) Long-Term Investments (2016 - 2026) Analysis & Trends
Scynexis (SCYX) has 5 years of Long-Term Investments data on file, last reported at $13.2 million in Q1 2026.
- Quarterly Long-Term Investments changed 0.02% year-over-year to $13.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.2 million (changed 0.02% YoY) and the FY2025 annual result came in at $16.2 million, up 2.53% from the prior year.
- Long-Term Investments fell to $13.2 million in Q1 2026, from $16.2 million in the prior quarter.
- In the past five years, Long-Term Investments ranged from a high of $23.6 million in Q4 2023 to a low of $1.7 million in Q2 2025.
- A 4-year average of $13.4 million and a median of $13.9 million in 2024 frame the typical range for Long-Term Investments.
- Annual changes were most pronounced in 2024 — Long-Term Investments soared 68.2% — and 2025, when it tumbled 83.71%.
- Tracing SCYX's Long-Term Investments over 4 years: stood at $23.6 million in 2023, then tumbled by 32.84% to $15.8 million in 2024, then rose by 2.53% to $16.2 million in 2025, then dropped by 19.04% to $13.2 million in 2026.
- The last three Long-Term Investments figures came in at $13.2 million (Q1 2026), $16.2 million (Q4 2025), and $1.7 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 92.58 Mn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 63.23 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 1.14 Bn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | 60.00 Mn |
| 10 | Scynexis | 61.90 Mn | -52.80 Mn | - | 17.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 17.05 Mn |
| Mar 31, 2026 | 13.15 Mn |
| Dec 31, 2025 | 16.25 Mn |
| Jun 30, 2025 | 1.74 Mn |
| Mar 31, 2025 | 13.16 Mn |
| Dec 31, 2024 | 15.85 Mn |
| Sep 30, 2024 | 16.12 Mn |
| Jun 30, 2024 | 10.66 Mn |
| Mar 31, 2024 | 13.94 Mn |
| Dec 31, 2023 | 23.59 Mn |
| Sep 30, 2023 | 17.12 Mn |
| Jun 30, 2023 | 6.34 Mn |
| Sep 30, 2016 | 6.03 Mn |